Next targeted therapy combo Cobimetinib plus Vemurafenib
Combimetinib plus Vemurafenib versus Vemurafenib alone
Copy number of BRAF not relevant for response
13% patients had additional mutations at the beginning BUT it has no effect on response.
and no surprise- combo works better than mono therapy!
No comments:
Post a Comment